相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab in men with heavily treated metastatic castrate-resistant prostate cancer
Matthew D. Tucker et al.
CANCER MEDICINE (2019)
Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades (vol 10, 1113, 2019)
Hao Chen et al.
FRONTIERS IN IMMUNOLOGY (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
1192OAssociation of tumour mutational burden with outcomes in patients with select advanced solid tumours treated with pembrolizumab in KEYNOTE-158
A Marabelle et al.
ANNALS OF ONCOLOGY (2019)
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Matthew D. Hellmann et al.
CANCER CELL (2018)
Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy
Emily Wynja et al.
JOURNAL OF IMMUNOTHERAPY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report
Won Jin Ho et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Evidio Domingo-Musibay et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le et al.
SCIENCE (2017)
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
N. Chaput et al.
ANNALS OF ONCOLOGY (2017)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member
Arno G. Beer et al.
ONCOTARGET (2016)
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
An integrative approach to predicting the functional effects of non-coding and coding sequence variation
Hashem A. Shihab et al.
BIOINFORMATICS (2015)
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies
J. S. Ross et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer
Shaobin Ni et al.
CANCER SCIENCE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Abstract 4060: Use of small animal MRI and cone-beam CT for image-guided radiotherapy of orthotopic tumors in mice
Jinzi Zheng et al.
CANCER RESEARCH (2012)
Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
Sergey I. Nikolaev et al.
NATURE GENETICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells
H. Prazeres et al.
ONCOGENE (2011)
Aberrant Methylation Impairs Low Density Lipoprotein Receptor-Related Protein 1B Tumor Suppressor Function in Gastric Cancer
Yen-Jung Lu et al.
GENES CHROMOSOMES & CANCER (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Ectodomains of the LDL Receptor-Related Proteins LRP1b and LRP4 Have Anchorage Independent Functions In Vivo
Martin F. Dietrich et al.
PLOS ONE (2010)
Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia
Kristen H. Taylor et al.
CANCER RESEARCH (2007)
Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior
F. B. Rahmatpanah et al.
LEUKEMIA (2006)
Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma
Takayuki Nakagawa et al.
CANCER SCIENCE (2006)
Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines
G Roversi et al.
ONCOGENE (2006)
Common fragile sites, extremely large genes, neural development and cancer
DI Smith et al.
CANCER LETTERS (2006)
Putative gene loci associated with carcinogenesis and metastasis of endocervical adenocarcinomas of uterus determined by conventional and array-based CGH
Y Hirai et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma
I Sonoda et al.
CANCER RESEARCH (2004)
Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake
NS Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis
P Pineau et al.
HEPATOLOGY (2003)
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer
S Langbein et al.
LABORATORY INVESTIGATION (2002)
The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL receptor-related protein
CX Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Genomic organization of a new candidate tumor suppressor gene, LRP1B
CX Liu et al.
GENOMICS (2000)
分享论文
